Jump to content

Viness Pillay

From Wikipedia, the free encyclopedia
Professor
Viness Pillay
Born1970
Died24 July 2020
Citizenship South Africa
OccupationPharmacist
Children1
AwardsNational Research Foundation (NRF)
Academic background
Alma materUniversity of the Witwatersrand, Johannesburg

Viness Pillay FAAS (1970–2020) was a South African professor of pharmacy at the University of the Witwatersrand in Johannesburg.[1][2] He was the Director of the Wits Advanced Drug Delivery Platform (WADDP), a member of African Academy of Sciences, Academy of Translational Medicine Professionals (ATMP) and a beneficiary of the 2013 Olusegun Obasanjo Innovative Award for developing the RapiDiss Wafer Technology as an innovative way to provide effective anti-retroviral (ARV) drug therapy to children afflicted with HIV/AIDS.[3][4][5][6][7]

Education

[edit]

He obtained his master's degree in pharmacy from the University of Durban-Westville (South Africa) in 1996 and bagged his PhD at Temple University in 2000 as a Fulbright Scholar.[6]

Scientific contributions

[edit]

He developed RapiDiss Wafer Technology as an innovative way to provide effective anti-retroviral (ARV) drug therapy to children afflicted with HIV/AIDS. He developed the world's fastest dissolving matrix for the onset of rapid drug action in the human body, a neural device for therapeutic intervention in spinal cord injury and novel wound healing technologies. He also came up with his own molecular modelling paradigms called PEiGOR Theory - Pillay's Electro-influenced Geometrical Organization-Reorganization. This theory was published in the International Journal of Pharmaceutics.[6][7][5][3]

Fellowship and membership

[edit]

He was elected a Fellow of the Academy of Science of South Africa in 2012. He was also a member of the American Chemical Society, the American Association of Pharmaceutical Scientists, the New York Academy of Sciences, the Academy of Pharmaceutical Sciences of South Africa, and The Biomaterials Network.[6]

Awards and honours

[edit]

He was a beneficiary of National Research Foundation (NRF) Awards.[8]

Death

[edit]

Pillay died on 24 July 2020 after a lengthy illness. He left behind a wife and a daughter.[1][2]

References

[edit]
  1. ^ a b Yahya, Choonara (2020-12-01). "Professor Viness Pillay (1970–2020) : obituary". SA Pharmaceutical Journal. 87 (5): 48–49. hdl:10520/ejc-mp_sapj-v87-n5-a16.
  2. ^ a b "African Academy of Sciences loses a Fellow | The AAS". www.aasciences.africa. Retrieved 2022-11-19.
  3. ^ a b "Professor Viness Pillay wins the Olusegun Obasanjo Prize – ACGT". acgt.co.za. Retrieved 2022-11-19.
  4. ^ Bawa, Priya; Pradeep, Priyamvada; Kumar, Pradeep; Choonara, Yahya E.; Modi, Girish; Pillay, Viness (2016-12-01). "Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders". Drug Discovery Today. 21 (12): 1886–1914. doi:10.1016/j.drudis.2016.08.001. ISSN 1359-6446. PMID 27506871.
  5. ^ a b "Nigeria: Pillay Is Winner of Obasanjo Prize for Innovation".
  6. ^ a b c d "Pillay Viness | The AAS". www.aasciences.africa. Retrieved 2022-11-19.
  7. ^ a b "Viness Pillay | The AAS". www.aasciences.africa. Retrieved 2022-11-19.
  8. ^ Rapoo, Tsholanang (2019-09-28). "Witsies recognised for scientific research and community impact". Wits Vuvuzela. Retrieved 2022-11-19.